• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以色列犹太宫颈癌患者和健康女性中p53基因第72位密码子的多态性

Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women.

作者信息

Arbel-Alon S, Menczer J, Feldman N, Glezerman M, Yeremin L, Friedman E

机构信息

Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel.

出版信息

Int J Gynecol Cancer. 2002 Nov-Dec;12(6):741-4. doi: 10.1046/j.1525-1438.2002.01124.x.

DOI:10.1046/j.1525-1438.2002.01124.x
PMID:12445252
Abstract

Recently it has been found that the presence of homozygous arginine polymorphism at codon 72 of p53, represents a significant risk factor in the development of HPV-associated cervical cancer. The incidence of cervical carcinoma is persistently very low in Israeli Jewish women for unknown reasons. The incidence among those of North African origin is relatively higher. The aim of the present study was to assess the frequency distribution of the p53 homozygous arginine polymorphism in cervical cancer patients and in a population sample of healthy Israeli Jewish women in order to determine whether the incidence pattern among them is genetically based. The cases consisted of 23 Israeli Jewish patients with histologically confirmed squamous cell carcinoma of the cervix. A group of 162 randomly chosen Israeli Jewish healthy participants, considered to represent the general population, comprised the controls. The germline p53 polymorphism at codon 72 was determined by PCR in DNA obtained from a blood sample taken from each subject. Homozygous arginine was found in 34.8% of cases and in only 14.8% of controls. This difference was statistically significant (P = 0.01). The frequency of homozygous arginine polymorphism in controls was lower than in any other population hitherto reported. It was significantly more common among those of North African than among those of other origin (30.3% vs. 10.8%; P < 0.01). It may be assumed that the low incidence of cervical cancer in Israeli Jewish women and the differences between the ethnic groups may be related to the frequency pattern of the homozygous arginine p53 polymorphism

摘要

最近发现,p53基因第72位密码子存在纯合精氨酸多态性是HPV相关宫颈癌发生的一个重要危险因素。以色列犹太女性宫颈癌的发病率一直很低,原因不明。北非裔女性的发病率相对较高。本研究的目的是评估宫颈癌患者和以色列犹太健康女性人群样本中p53纯合精氨酸多态性的频率分布,以确定她们之间的发病模式是否基于遗传因素。病例包括23名经组织学确诊为宫颈鳞状细胞癌的以色列犹太患者。一组162名随机选择的以色列犹太健康参与者作为对照组,他们被认为代表了一般人群。通过聚合酶链反应(PCR)检测每个受试者血样中DNA的p53基因第72位密码子的种系多态性。在34.8%的病例中发现了纯合精氨酸,而在对照组中仅为14.8%。这种差异具有统计学意义(P = 0.01)。对照组中纯合精氨酸多态性的频率低于迄今报道的任何其他人群。在北非裔人群中比在其他血统人群中更为常见(30.3%对10.8%;P < 0.01)。可以推测,以色列犹太女性宫颈癌的低发病率以及不同种族之间的差异可能与p53纯合精氨酸多态性的频率模式有关

相似文献

1
Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women.以色列犹太宫颈癌患者和健康女性中p53基因第72位密码子的多态性
Int J Gynecol Cancer. 2002 Nov-Dec;12(6):741-4. doi: 10.1046/j.1525-1438.2002.01124.x.
2
The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia.以色列犹太裔患有宫颈和外阴肿瘤的女性肿瘤组织中HPV 16、18及p53免疫组化染色情况。
Eur J Gynaecol Oncol. 2000;21(1):30-4.
3
HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India.印度宫颈癌变/癌症患者中HPV16/18的流行情况及宫颈癌患者的p53基因型
Gynecol Oncol. 2002 Aug;86(2):157-62. doi: 10.1006/gyno.2002.6735.
4
P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women.南非女性中P53密码子72多态性与人类乳头瘤病毒类型和宫颈癌的关系
Int J Gynecol Cancer. 2002 Jul-Aug;12(4):383-8. doi: 10.1046/j.1525-1438.2002.01109.x.
5
Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.p53基因第72位密码子多态性作为人乳头瘤病毒相关的宫颈鳞状上皮内病变和浸润性宫颈癌患者的一个风险因素。
Carcinogenesis. 1999 Sep;20(9):1733-6. doi: 10.1093/carcin/20.9.1733.
6
G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.基于p53基因多态性探讨HPV 16 E6与子宫颈癌G2期检查点的关系及其筛查价值
Gynecol Oncol. 2003 Jul;90(1):15-22. doi: 10.1016/s0090-8258(03)00198-7.
7
Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India.印度东部烟草成瘾的口腔鳞状细胞癌(OSCC)患者中高危型人乳头瘤病毒的流行情况及其与P53密码子72多态性的关联
Int J Cancer. 2002 Feb 10;97(5):649-53. doi: 10.1002/ijc.10112.
8
p53 polymorphism at codon 72--does it constitute a risk for squamous intraepithelial lesions and invasive cancer of the cervix in Central Europeans?第72位密码子处的p53基因多态性——它会增加中欧人群患宫颈鳞状上皮内病变和浸润性宫颈癌的风险吗?
Wien Klin Wochenschr. 2000 Sep 29;112(18):817-20.
9
p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.p53 密码子 72 多态性与摩洛哥妇女宫颈癌风险。
Med Oncol. 2010 Sep;27(3):861-6. doi: 10.1007/s12032-009-9297-6. Epub 2009 Sep 23.
10
Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.人乳头瘤病毒16型阳性宫颈癌中病毒DNA的整合状态及p53密码子72多态性
Anticancer Res. 2000 May-Jun;20(3B):2161-7.

引用本文的文献

1
Association between the polymorphisms and cervical cancer risk: an updated meta-analysis.多态性与宫颈癌风险之间的关联:一项更新的荟萃分析。
Front Oncol. 2025 Feb 21;15:1461737. doi: 10.3389/fonc.2025.1461737. eCollection 2025.
2
A Review of Cancer Genetics and Genomics Studies in Africa.非洲癌症遗传学与基因组学研究综述
Front Oncol. 2021 Feb 15;10:606400. doi: 10.3389/fonc.2020.606400. eCollection 2020.
3
Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.基于血液的人乳头瘤病毒相关癌症生物标志物:系统评价和荟萃分析。
Cancer. 2021 Mar 15;127(6):850-864. doi: 10.1002/cncr.33221. Epub 2020 Dec 3.
4
ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women.吉尔吉斯斯坦女性中的TR53密码子72多态性与人类乳头瘤病毒相关宫颈癌
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1057-1062. doi: 10.31557/APJCP.2019.20.4.1057.
5
TP53 codon 72 polymorphism and susceptibility to cervical cancer in the Chinese population: an update meta-analysis.TP53基因第72位密码子多态性与中国人群宫颈癌易感性:一项更新的荟萃分析。
Int J Clin Exp Med. 2015 Jun 15;8(6):9055-62. eCollection 2015.
6
A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.关于宿主对人乳头瘤病毒感染及进展为宫颈癌的遗传易感性的综合综述。
Indian J Hum Genet. 2011 Sep;17(3):132-44. doi: 10.4103/0971-6866.92087.
7
The Jerusalem Perinatal Study cohort, 1964-2005: methods and a review of the main results.耶路撒冷围产期研究队列,1964 - 2005年:方法及主要结果综述
Paediatr Perinat Epidemiol. 2007 May;21(3):256-73. doi: 10.1111/j.1365-3016.2007.00799.x.
8
Cancer in Jews: introduction and overview.犹太人中的癌症:引言与概述
Fam Cancer. 2004;3(3-4):177-92. doi: 10.1007/s10689-004-9538-y.
9
Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer.南非女性中干扰素-γ等位基因分布的种族差异,但与宫颈癌无关联。
J Carcinog. 2003 May 16;2(1):3. doi: 10.1186/1477-3163-2-3.